Orexo Files NDA For Dissolving Zolpidem
This article was originally published in The Pink Sheet Daily
Executive Summary
Payers likely to favor generic Ambien for short-term insomnia, analyst tells “The Pink Sheet” DAILY.
You may also be interested in...
Positive Osteoarthritis Efficacy Results For Ketoprofen Buoy Endo
Endo also reports strong third quarter sales driven by Lidoderm pain patch.
Swedish Specialty Pharma Meda Acquires MedPointe In $800 Million Transaction
Meda also acquires MedPointe’s 500-strong U.S. sales force in the deal.
Ambien Generics Grab 5 Percent of Insomnia Market In First Week
Zolpidem generics launched April 23 with 13 ANDA approvals.